ResApp Health (ASX:RAP) grants Sanofi an option to licence startup outcomes

  • Home
  • Company News
  • ResApp Health (ASX:RAP) grants Sanofi an option to licence startup outcomes
15Nov

ResApp Health (ASX:RAP) grants Sanofi an option to licence startup outcomes

 

Digital health company ResApp Health (ASX:RAP) has penned an agreement which grants Sanofi an exclusive license to use the outcomes generated under the Startup Creasphere incubator program.

Under this program the 2 companies are collaborating on building a smartphone application which will leverage ResApp’s novel cough-based diagnostic system to provide at-home support to consumers.

ResApp has granted Sanofi the option to negotiate and acquire exclusive rights to develop, manufacture and commercialise a respiratory disease self-assessment application specifically for consumers.

Shares in ResApp Health (ASX:RAP) are trading 1.9 per cent higher at 28 cents.
 
Copyright 2019 – Finance News Network


Source: Finance News Network

Share this post

Related Posts

09Oct

Jupiter Mines (ASX:JMS) appoints non-executive director

09 Oct 2019 - Jupiter Mines (ASX:JMS) Non-Executive Director Hans Mende has been appointed to the Jupiter Board, effective immediately.

Read More
13Mar

Fluence Corporation (ASX:FLC) sells Aspiral for China Rail in Inner Monogolia

13 Mar 2020 - Fluence Corporation (ASX:FLC) is pleased to announce that it has entered into a new province with an Aspiral sale to Beijing China Railway Science New Technology Co.

Read More
06Apr

Caltex (ASX:CTX) to extend planned refinery shutdown

06 Apr 2020 - Caltex (ASX:CTX) is bringing forward the planned shut down for the Lytton refinery from May 2020.

Read More
30Aug

BlueScope Steel sued for allegedly attempting to fix prices

30 Aug 2019 - BlueScope Steel (ASX:BSL) informed the ASX today that the Australian Competition and Consumer Commission (ACCC) has started civil proceedings against them and their former employee Jason Ellis alleging contraventions of the Australian competition law cartel provisions.

Read More
07Jul

Sezzle (ASX:SZL) reports a record second quarter 2020

07 Jul 2020 - Installment payment platform, Sezzle (ASX:SZL) has released their key operating metrics for the quarter showing Underlying Merchant Sales (UMS) expected to reach an annualized pace of $1.4 billion by the end of 2020.

Read More
21Aug

Redbubble Group (ASX:RBL) posts first EBITDA profit since its IPO

21 Aug 2020 - Redbubble Group’s (ASX:RBL) gross profit rose 42 per cent to $134 million for the year ended 30 June 2020.

Read More
02Oct

Mach7 Technologies awarded US patent for its Management Studio

02 Oct 2019 - Mach7 Technologies (ASX:M7T), a company specialising in innovative data management solutions for healthcare providers, has been awarded a United States Patent for its “Dynamic Media Object Management System”.

Read More
24Jan

Village Roadshow (ASX:VRL) receive a second take-over bid

24 Jan 2020 - Village Roadshow (ASX:VRL) has received a second take-over bid, this time from BGH Capital.

Read More
19May

Cochlear (ASX:COH) has rehearing of appeal in the US denied

19 May 2020 - Cochlear (ASX:COH) today announced that the United States Court of Appeals has denied its petition for a rehearing of the appeal in the patent infringement case against them.

Read More
21Feb

OceanaGold (ASX:OGC) reports a loss of US$150.4 million

19 Feb 2021 - OceanaGold (ASX:OGC) has a reported a loss of US$150.4 million compared to a $14.5 million profit a year ago.

Read More